|Articles|June 24, 2015
Schulman IRB Acquires Absolute Research
Advertisement
Schulman Associates IRB announced the acquisition of Missouri-based
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
2
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
3
Subcutaneous Saphnelo Shows Positive Phase III Results in Systemic Lupus Erythematosus
4
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
5